321. The EMTCT is a high priority of the GoSL. The Office of the First Lady is leading the national EMTCT programme which is guided by a national EMTCT Strategic Plan (2013-2015). PMTCT services are integrated into national antenatal care services and are designed in accordance with the new WHO recommendations on ARV treatment for PMTCT – that is all HIV positive pregnant women are treated for life. The testing of pregnant women has been integrated into the biannual mother and child health week since 2011 and media, education and communication activities on PMTCT have been undertaken by the GoSL and its partners. 322. A PMTCT Data Quality Audit is being undertaken by the GoSL with the support of UNICEF, WHO and UNAIDS. The dual objectives of the audit are to assess the quality of PMTCT data and to describe the estimated need for PMTCT. 323. A national paediatric HIV and AIDS care scale-up plan was launched in 2010 with the objective of increasing the number of health facilities providing paediatric care to 111 by 2014. The national public health laboratory has been upgraded to include early infant diagnosis using the PCR technology. 324. The GoSL has made progress in the fight against HIV and AIDS. The GoSL has significantly increased coverage of key interventions, as is evident from the table below. Table 3: Coverage of key HIV and AIDS interventions 2011 to 2012 Coverage % of HIV-positive pregnant women who received ARV to reduce the risk of mother-to-child transmission during pregnancy and delivery % of HIV-positive pregnant women who receive a COMPLETE COURSE or ARV to reduce the risk of MTCT during pregnancy and delivery 2011 2012 74 93 NA 36 % of infant born to HIV positive women who are provided with ART to reduce the risk of HIV transmission during breastfeeding % of infants born to HIV/infected women started cotrimoxizole prophylaxis within two months of birth 1.47 23.4 13.28 NA 2.69 % of eligible adults currently receiving ARV 44 41 % of eligible children currently receiving ARV 21 27 % of infants born to HIV-positive women receiving a virological test for HIV within 2 months of birth Sources: Programmatic data 2012 NACP annual report and UNGASS (2011) national AIDS control Programme (NACP) Report 2012 325. The preceding initiatives have contributed to the GoSL’s halting of the spread of HIV, reducing prevalence among pregnant women, almost doubling the number of pregnant women that are tested as a result of integration of testing into ANC services, significantly increasing Early Infant Diagnosis; and reducing new infections among children aged 0-14 years from 1187 new infections in 2007 to 315 in 2012. 326. The next major step for the GoSL is to roll out universal ARV treatment. There are a number of challenges that will have to be overcome to realise this objective, including weak laboratory capacity and the limited number of health facilities providing ARV treatment and PMTCT services. At present, out of the 1,200 facilities, only 131 are 7. Health and Welfare  85